NCT02914496

Brief Summary

For many people living with type 1 diabetes it is a challenge to achieve good glucose control. Barely 20% reaches the goal level and many people experience self-care as complex, demanding and stressful. The purpose of this study is to evaluate the effect of a stress-management program on glucose control, self-care and psychosocial factors. The program is based on Acceptance and Commitment Therapy (ACT), a specific form of Cognitive behavior therapy (CBT). A total of 70 adult patients with type 1 diabetes from Ersta hospital will be recruited. Half of them will receive the intervention and the other half will continue with their regular diabetes care. A licensed psychologist specialised in CBT and a diabetes specialist nurse will be leading the intervention that is given in a group format. The program consists of seven 2-hour sessions given over 14 weeks. Glucose control, self care and stress will be measured at inclusion, after session four and seven, at six , 12 and 24 months and finally after 5 years

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
81

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 15, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 26, 2016

Completed
19 days until next milestone

Study Start

First participant enrolled

October 15, 2016

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
5.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

July 25, 2025

Status Verified

July 1, 2025

Enrollment Period

3.7 years

First QC Date

September 15, 2016

Last Update Submit

July 22, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • HbA1c

    Measure of long term glucose control

    12 months post inclusion

Secondary Outcomes (6)

  • Manchester Short Assessment of Quality of life

    1-5 years post inclusion

  • Depression Anxiety stress scales

    1-5 years post inclusion

  • The Hypoglycemia Fear Survey emotions, depression, anxiety, fear of hypoglycemia, general and diabetes related distress.

    1-5 years post inclusion

  • The Problem Areas in Diabetes (Swe-PAID-20) Scale

    1-5 years post inclusion

  • Acceptance and action diabetes questionnaire

    1-5 years post inclusion

  • +1 more secondary outcomes

Study Arms (2)

Diabetes in Balance

EXPERIMENTAL

The intervention consists of the manual-based CBT-group intervention "Diabetes in Balance". It is given in a group format with six to ten participants and consists of 7 sessions. The sessions are given bi-weekly for two hours. Each session has a specific theme such as "Stress and acceptance" "The life-compass; what is important in my life". The participants also conduct assignments related to the themes between the sessions. A licensed psychologist specialised in CBT and a diabetes specialist nurse, both trained in "ACT-stress management" will be leading the intervention group.

Behavioral: Acceptance and Commitment Therapy (ACT)

Control

NO INTERVENTION

The control group receives regular care including regular visits at the out-patient clinic, 3-4 times per year.

Interventions

ACT is a specific form of Cognitive behavior therapy (CBT) which will be given as a course consisting of seven sessions where each session is two hours long.

Also known as: Diabetes in Balance
Diabetes in Balance

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 1 diabetes
  • Duration of disease \>2 years -
  • Hb1c\>60 mmol/mol

You may not qualify if:

  • Insufficient knowledge to understand and express themselves in Swedish
  • Untreated or severe ongoing psychiatric disease
  • Cortisone treatment
  • Untreated thyroid disease
  • Insulin pump therapy started since \<3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ersta sjukhus

Stockholm, Stockholm County, 11691, Sweden

Location

Related Publications (2)

  • Wijk I, Amsberg S, Johansson UB, Livheim F, Toft E, Anderbro T. Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trial. BMJ Open. 2023 Dec 14;13(12):e072061. doi: 10.1136/bmjopen-2023-072061.

  • Amsberg S, Wijk I, Livheim F, Toft E, Johansson UB, Anderbro T. Acceptance and commitment therapy (ACT) for adult type 1 diabetes management: study protocol for a randomised controlled trial. BMJ Open. 2018 Nov 28;8(11):e022234. doi: 10.1136/bmjopen-2018-022234.

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Interventions

Acceptance and Commitment Therapy

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Therese Anderbro, AssProf

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 15, 2016

First Posted

September 26, 2016

Study Start

October 15, 2016

Primary Completion

June 30, 2020

Study Completion

December 31, 2025

Last Updated

July 25, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Data will primarily be presented at the group level. Individual data will where appropriate be anonymised

Locations